P-cadherin expression and basal-like subtype in breast cancers

Medical Oncology

Volumn 29, Issue 4, 2012, Pages 2606-2612

  Liu, N ^a   Yu, Q ^a,b   Liu, T J ^a   Gebreamlak, Estifanos P ^a   Wang, S L ^a   Zhang, R J ^a   Zhang, J ^a   Niu, Y ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Jinghai Hospital   (China)

Author keywords

Basal like subtype; Breast cancer; P cadherin

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; LUMINAL A; LUMINAL B; P CADHERIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL DECISION MAKING; DISTANT METASTASIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; FEMALE; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; MIDDLE AGED; RECEPTORS, ESTROGEN;

EID: 84868001125     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0218-8     Document Type: Article

References (38)

1. Liu H, Xun P, Chen K-x, et al. The trend of clinical characteristics and prognosis of women's breast cancer 1981-2000. Natl Med J China. 2007;87(34):2405-7.
2. Alizadeh AA, Ross DT, Perou CM, et al. Towards a novel classification of human malignancies based on gene expression patterns. J Pathol. 2001;195:41-52.
3. Reis-Filho JS, Simpson PT, Gale T, et al. The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. Pathol Res Pract. 2005;201:713-25.
4. Lacroix M, Toillon RA, Leclercq G. Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics. Endocr Relat Cancer. 2004;11:497-522.
5. Simpson PT, Reis-Filho JS, Gale T, et al. Molecular evolution of breast cancer. J Pathol. 2005;205:248-54.
6. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747-52.
7. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98:10869-74.
8. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003;100:8418-23.
9. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530-6.
10. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10:5367-74.
11. Rouzier R, Perou CM, Symmans WF, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res. 2005;11:5678-85.
12. Rakha EA, El-Sayed ME, Green AR, et al. Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression. Histopathology. 2007;50:434-8.
13. Calza S, Hall P, Auer G, et al. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res. 2006;8:R34.
14. Brenton JD, Carey LA, Ahmed AA, et al. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol. 2005;23:7350-60.
15. Jumppanen M, Gruvberger-Saal S, Kauraniemi P, et al. Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers. Breast Cancer Res. 2007;9:R16.
16. Tang P, Wei B, David G, et al. Breast cancer molecular subtypes and clinical application. Chin J Pathol. 2009;38:13-7.
17. Sousa B, Paredes J, Milanezi F, et al. P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study. Histol Histopathol. 2010;25(8):963-74.
18. Turashvili G, McKinney SE, Goktepe O, et al. P-cadherin expression as a prognostic biomarker in a 3,992 case tissue microarray series of breast cancer. Mod Pathol. 2011;24(1):64-81.
19. Knudsen KA, Wheelock MJ. Cadherins and the mammary gland. J Cell Biochem. 2005;95:488-96.
20. Rakha EA, Putti TC. Abd El-Rehim DM, et al. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol. 2006;208:495-506.
21. Tavassoli FA, Devilee P, editors. The WHO classification of tumors of the breast and female genital organs (M). Lyon: IARC Press; 2003. p. 10-112.
22. Miller DV, Leontovich AA, Lingle WL, et al. Utilizing Nottingham prognostic index in microarray gene expression profiling of breast carcinomas. Mod Pathol. 2004;17:756-64.
23. Rakha EA, Ellis IO. Triple-negative/basal-like breast cancer: review. Pathology. 2009;41:40-7.
24. Paredes J, Albergaria A, Oliveira JT, et al. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res. 2005;11:5869-77.
25. Matos I, Dufloth R, Alvarenga M, et al. p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch. 2005;447:688-94.
26. Paredes J, Correia AL, Ribeiro AS, et al. P-cadherin expression in breast cancer: a review. Breast Cancer Res. 2007;9:214.
27. Van Marck V, Stove C, Van Den Bossche K, et al. P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. Cancer Res. 2005;65:8774-83.
28. Madhavan M, Srinivas P, Abraham E, et al. Cadherins as predictive markers of nodal metastasis in breast cancer. Mod Pathol. 2001;14:423-7.
29. Kovacs A, Dhillon J, Walker RA. Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas. Mol Pathol. 2003;56:318-22.
30. Paredes J, Stove C, Stove V, et al. P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer Res. 2004;64:8309-17.
31. Albergaria A, Ribeiro AS, Pinho S, et al. ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation. Hum Mol Genet. 2010;19(13):2554-66.
32. Ribeiro AS, Albergaria A, Sousa B, et al. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene. 2010;29(3):392-402.
33. Sarrió D, Palacios J, Hergueta-Redondo M, et al. Functional characterization of E- and P-cadherin in invasive breast cancer cells. BMC Cancer. 2009;3(9):74.
34. Liu N, Niu Y, Wang SL, et al. Diagnostic and prognostic significance of FOXA1 expression in molecular subtype of breast invasive ductal carcinoma. Zhonghua Yi Xue Za Zhi. 2010;90(20):1403-7.
35. Niu Y. Basal-like carcinoma: one subtype of breast cancer recognized recently. Chin J Pathol. 2007;36:849-52.
36. Yang GZ, Gao LX, Ding HY. Basal-like subtype of breast cancer. Chin J Diag Pathol. 2007;14:241-3.
37. Gao LX, Yang GZ, Ding HY, et al. Morphological features of basal-like subtype invasive carcinoma of breast. Chin J Pathol. 2008;37:83-7.
38. Arnes JB, Brunet JS, Stefansson I, et al. Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer. Clin Cancer Res. 2005;11:4003-11.